You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for EB 1089
EB 1089 is a vitamin D receptor (VDR) agonist; analog of calcitriol (Cat. No. 2551). Exhibits anti-tumor and anti-proliferative activity with reduced hypercalcemic effects. 60 times more potent in inhibiting MCF-7 cell growth in vitro; also shown to induce autophagy in MCF-7 cells. Reverses the effects of parathyroid hormone-related protein (PTHrP).
Technical Data for EB 1089
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for EB 1089
|Solubility||Soluble in DMSO and in ethanol|
References for EB 1089
References are publications that support the biological activity of the product.
Lu et al (2008) Vitamin D3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57. Mol.Cancer Ther. 7 1268 PMID: 18483314
Bhatia et al (2009) EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells. Mol.Cancer Ther. 8 1787 PMID: 19584236
Abdaimi et al (1999) Reversal of hypercalcaemia with the vitamin D analogue EB1089 in a human model of squamous cancer. Cancer Res, 59 3325
Ormerod et al (2008) The calci. analogue EB1089 impairs alveolarization and induces localized regions of increased fibroblast density in neonatal rat lung. Exp.Lung.Rs. 34 155
Hoyer-Hansen et al (2005) Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ. 12 1297 PMID: 15905882
If you know of a relevant reference for EB 1089, please let us know.
View Related Products by Product Action
Keywords: EB 1089, EB 1089 supplier, EB1089, VDR, agonist, Vitamin, D, receptors, seocalcitol, VDR-like, Seocalcitol, Receptors, Autophagy, 3993, Tocris Bioscience
3 Citations for EB 1089
Citations are publications that use Tocris products. Selected citations for EB 1089 include:
Hiranuma et al (2016) Expression of nephronectin is enhanced by 1α,25-dihydroxyvitamin D3. FEBS Open Bio 6 914 PMID: 27642554
Solomon et al (2014) VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells. Mol Cancer Res 12 1166 PMID: 24825850
Sharma et al (2015) A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089. Oncotarget 10 2346 PMID: 25629933
Do you know of a great paper that uses EB 1089 from Tocris? Please let us know.
Reviews for EB 1089
There are currently no reviews for this product. Be the first to review EB 1089 and earn rewards!
Have you used EB 1089?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.